Author
Listed:
- Hongwu Zheng
(Department of Medical Oncology,)
- Haoqiang Ying
(Department of Medical Oncology,)
- Haiyan Yan
(Department of Medical Oncology,)
- Alec C. Kimmelman
(Department of Medical Oncology,
Harvard Radiation Oncology Program,)
- David J. Hiller
(Stanford University, Stanford, California 94305, USA)
- An-Jou Chen
(Department of Medical Oncology,)
- Samuel R. Perry
(Department of Medical Oncology,
Center for Applied Cancer Science, Belfer Foundation Institute for Innovative Cancer Science,)
- Giovanni Tonon
(Department of Medical Oncology,)
- Gerald C. Chu
(Department of Medical Oncology,
Center for Applied Cancer Science, Belfer Foundation Institute for Innovative Cancer Science,
Department of Pathology,)
- Zhihu Ding
(Department of Medical Oncology,)
- Jayne M. Stommel
(Department of Medical Oncology,)
- Katherine L. Dunn
(Department of Medical Oncology,)
- Ruprecht Wiedemeyer
(Department of Medical Oncology,)
- Mingjian J. You
(Department of Medical Oncology,)
- Cameron Brennan
(Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA
Weill-Cornell Medical College, New York, New York 10065, USA)
- Y. Alan Wang
(Department of Medical Oncology,
Center for Applied Cancer Science, Belfer Foundation Institute for Innovative Cancer Science,)
- Keith L. Ligon
(Department of Medical Oncology,
Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA
Department of Pathology,
Division of Neuropathology,)
- Wing H. Wong
(Stanford University, Stanford, California 94305, USA)
- Lynda Chin
(Department of Medical Oncology,
Center for Applied Cancer Science, Belfer Foundation Institute for Innovative Cancer Science,
Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA)
- Ronald A. DePinho
(Department of Medical Oncology,
Center for Applied Cancer Science, Belfer Foundation Institute for Innovative Cancer Science,
Harvard Medical School, Boston, Massachusetts 02115, USA)
Abstract
Glioblastoma: large-scale genomics and a lab model The Cancer Genome Atlas, a large-scale genomics project to catalogue cancer-linked mutations, is starting to produce results. Glioblastoma, the most common brain cancer, was the first target for the project and the initial results, published AOP on 4 September, are now in print. Genes newly implicated in glioblastoma include tumour suppressors (NF1, RB1, ATM and APC) and several tyrosine kinase genes. Glioblastoma is extremely resistant to therapy, hence the potential importance of the development of a possible model system. Zheng et al. report that mice lacking the tumour suppressors p53 and Pten develop tumours resembling human glioblastomas, associated with increased Myc protein levels. As well as offering a potential system for testing therapeutics, this points to c-Myc as a possible drug target.
Suggested Citation
Hongwu Zheng & Haoqiang Ying & Haiyan Yan & Alec C. Kimmelman & David J. Hiller & An-Jou Chen & Samuel R. Perry & Giovanni Tonon & Gerald C. Chu & Zhihu Ding & Jayne M. Stommel & Katherine L. Dunn & R, 2008.
"p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation,"
Nature, Nature, vol. 455(7216), pages 1129-1133, October.
Handle:
RePEc:nat:nature:v:455:y:2008:i:7216:d:10.1038_nature07443
DOI: 10.1038/nature07443
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:455:y:2008:i:7216:d:10.1038_nature07443. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.